Johnson & Johnson (JNJ) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $255.59 -1.45%
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
OMID, BCML, CZNC, More
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.13, $0.01 better than the analyst estimate of $2.12. Revenue for the quarter came in at $24.8 billion versus the consensus estimate of $25.29 billion.
GUIDANCE:
Johnson & Johnson sees FY2022 EPS of $10.40-$10.60, versus the consensus of $10.37.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Erste Group Downgrades Johnson & Johnson (JNJ) to Hold
- UniFirst Corp (UNF) Misses Q4 EPS by 44c
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
